Dr. Lawrence Kauvar

Redwood City, California, United States
Trellis Bioscience, LLC was founded in 2010 by Dr. Lawrence Kauvar, Senior Vice President and Chief Scientific Officer. A team of experienced pharma and biotech executives with complementary skills is responsible for running the company. Dr. Kauvar was previously the founder and Chief Scientific Officer of Telik, a publically traded small molecule drug company focused on oncology (acquired by MabVax in 2014), and a co-founder of Promedior, a clinical stage anti-fibrotic company. He holds over 50 US patents for methods, tools and drug compounds and is one of the inventors of CellSpot™, Trellis' core technology. Dr. Kauvar holds an undergraduate degree in Mathematics from Harvard, a PhD from Yale in Molecular Biophysics and Biochemistry, and pursued postdoctoral studies at Caltech and UCSF.
Speaking In
5:15 PM - 5:30 PM
Wednesday, June 5
The CDC estimates that 70% of bacterial infections are drug resistant due to biofilms. Trellis'…